News tagged with age related macular degeneration
FDA panel unanimously backs Regeneron eye drug
(AP) -- A panel of federal health experts voted unanimously in favor of a new eye drug from Regeneron, bringing the company one step closer to competing against a blockbuster Roche drug that currently dominates the market.
Medicine & Health / Medications
Jun 17, 2011 |
not rated yet |
0
First patients enroll in US stem cell trials on blindness
The first clinical trials that examine the use of stem cells to treat two forms of blindness are ready to begin now that patients have been enrolled, a US company announced on Thursday.
Medicine & Health / Medical research
Jun 16, 2011 |
5 / 5 (1) |
0
Certain new therapies for age-related eye disease do not appear to increase heart risks
Newer treatments for age-related macular degeneration (AMD)including an intravitreous (into the eye) injection of a chemotherapy drug and use of a related compound approved for use against the eye diseasedo not ...
Medicine & Health / Diseases, Conditions, Syndromes
Oct 11, 2010 |
not rated yet |
0
Nutrition's potential to save sight
While 20/20 vision is a symbol of visual acuity, between now and the year 2020, more and more people will experience some extent of vision loss due to age-related macular degeneration (AMD) and other sight-robbing diseases.
Jul 01, 2010 |
1 / 5 (1) |
0
Ingredient in red wine may prevent some blinding diseases
found in red wine, grapes, blueberries, peanuts and other plants — stops out-of-control blood vessel growth in the eye, according to vision researchers at Washington University School of Medicine in St. Louis.
Medicine & Health / Medical research
Jun 25, 2010 |
4.2 / 5 (5) |
0
|
3-D snapshots of eyes reveal details of age-related blindness
To get a better look at the abnormalities that cause age-related macular degeneration (AMD), the leading cause of vision loss in Americans and Europeans over 50, the research groups of James Fujimoto at the Massachusetts ...
Medicine & Health / Medical research
Mar 19, 2009 |
not rated yet |
0